Senestech Inc

Senestech Inc(SNES)股票分析

$1.080

+0.075 (+6.93%)收盤時

Loading chart…
最高
1.090
開盤
1.010
成交量加權均價
1.04
成交量
95.53K
市值
2.94M
最低
0.960
成交金額
99.67K
企業價值/稅息折舊攤銷前利潤(TTM)
-0.21

SenesTech, Inc. develops and commercializes products for managing animal pest populations, initially rat populations, through fertility control. The Company’s product lines of fertility control products are: ContraPest, Evolve Rat, and Evolve Mouse. Its product, ContraPest, is a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide (VCD) and triptolide. ContraPest targets the reproductive systems of both male and female Norway and roof rats beginning with the first breeding cycle following consumption, which can lead to sustained reductions in the rat population. The Evolve Rat is a soft bait product that contains the active ingredient, cottonseed oil, which reduces fertility in both male and female rats. The Evolve Mouse, a modified version of soft bait technology containing the active ingredient cottonseed oil, which limits reproduction of male and female mice after one to two breeding cycles following consumption.

AI 分析 of Senestech Inc (SNES)

買進

Senestech Inc is a good buy right now due to its recent positive momentum, with a 5-day price increase of 29.85% and a record gross margin of 73.64%. The stock is currently priced at $0.84, which is below the $1.00 minimum bid price requirement set by Nasdaq, posing a risk of delisting. However, the company has shown significant revenue growth, with Q2 revenue reaching $770,000, a 56% sequential increase, indicating a strong market performance. The main risk is the Nasdaq notification regarding the low stock price, which could affect investor confidence.

分析師評級(2)

上檔空間 +825.93%
買進
2 買進
0 持有
0 賣出
目前: 1.08
最低
10.00
平均
10.00
最高
10.00

HC Wainwright & Co.

2024-12-13

目標價

$10

強烈買進

HC Wainwright & Co.

2024-12-12

目標價

$10

強烈買進

HC Wainwright & Co.

2024-05-14

目標價

$3.5

強烈買進

HC Wainwright & Co.

2023-12-28

目標價

$3.5

強烈買進

HC Wainwright & Co.

2023-05-24

目標價

$48

強烈買進

估值指標

Senestech Inc(SNES)目前預期本益比為 3.40,5 年平均預期本益比為 -0.38。

預期本益比

嚴重高估
5 年均值 P/E
-0.38
目前P/E
3.40
高估
1.20
低估
-1.95

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
-0.44
目前EV/EBITDA
-0.21
高估
0.60
低估
-1.49

預期股價營收比

合理
5 年均值 P/S
2.25
目前P/S
0.98
高估
4.47
低估
0.04

Alphio AI 對 SNES 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%SNES

$3.91

情境價格

基

基準

基準 · 50%SNES

$3.75

情境價格

悲

悲觀

悲觀 · 25%SNES

$3.33

情境價格

事件時間軸

2026-10-19 (ET)

09:30:00

SenesTech Reports Evolve Rat Control Pilot Results

2026-10-15 (ET)

08:30:00

SenesTech Achieves First $1M Revenue in Q3

2026-09-23 (ET)

09:00:00

SenesTech Launches Evolve Products on Grove Collaborative

2026-08-31 (ET)

09:00:00

SenesTech Reduces Rodent Activity by 43% in Massachusetts

2026-08-03 (ET)

09:00:00

SenesTech's Online Subscription Customers More Than Doubled

資訊

SNES 常見問題 —— 由 Alphio AI 解答

SenesTech, Inc. develops and commercializes products for managing animal pest populations, initially rat populations, through fertility control. The Company’s product lines of fertility control products are: ContraPest, Evolve Rat, and Evolve Mouse. Its product, ContraPest, is a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide (VCD) and triptolide. ContraPest targets the reproductive systems of both male and female Norway and roof rats beginning with the first breeding cycle following consumption, which can lead to sustained reductions in the rat population. The Evolve Rat is a soft bait product that contains the active ingredient, cottonseed oil, which reduces fertility in both male and female rats. The Evolve Mouse, a modified version of soft bait technology containing the active ingredient cottonseed oil, which limits reproduction of male and female mice after one to two breeding cycles following consumption. It operates in the Basic Materials sector (AGRICULTURAL CHEMICALS industry).

Senestech Inc is a good buy right now due to its recent positive momentum, with a 5-day price increase of 29.85% and a record gross margin of 73.64%. The stock is currently priced at $0.84, which is below the $1.00 minimum bid price requirement set by Nasdaq, posing a risk of delisting. However, the company has shown significant revenue growth, with Q2 revenue reaching $770,000, a 56% sequential increase, indicating a strong market performance. The main risk is the Nasdaq notification regarding the low stock price, which could affect investor confidence.

2 analysts cover SNES: 2 rate it Buy, 0 Hold and 0 Sell. The average price target is 10.00.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易